My uncle, who is retired from the health management industry, tipped this one to me last year - wish I'd listened:
Heartware (HIN) put out a upgraded revenue statement to the ASX yesterday at 10.01am, but nobody gave a toss. But its dual listing in the USA (HTWR) went up more than 11% overnight on the same news.
Of course, this morning, HIN gapped up from 2.50 to 2.78. Why do Aussie companies need to follow the US lead sometimes? We had the news, yet nobody was game to buy in. But if you look at the HIN chart, it's been in a strong uptrend. It's not a daytrade share, but it was an easy overnight hold play, there for the asking.
